Researchers from the University of Illinois at Urbana-Champaign have developed photo-luminescent carbon nanodots that exhibit reversible switching of their optical properties in cancer cells. The team’s work was published in the Journal of the American Chemical Society.
The carbon nanoparticles could be applied to intracellular imaging and drug delivery, the authors said.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.